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Abstract
Introduction
The  accurate  identification  of  acute  stroke  cases  is  an 
essential requirement of hospital-based stroke registries. 
We determined the accuracy of acute stroke diagnoses in 
Michigan hospitals participating in a prototype of the Paul 
Coverdell National Acute Stroke Registry.
Methods
From  May  through  November  2002,  registry  teams  (ie, 
nurse  and  physician)  from  15  Michigan  hospitals  pro-
spectively identified all suspect acute stroke admissions 
and classified them as stroke or nonstroke. Medical chart 
data were abstracted for a random sample of 120 stroke 
and  120  nonstroke  admissions.  A  blinded  independent 
physician panel then classified each admission as stroke, 
nonstroke, or unclassifiable, and the overall accuracy of 
the registry was determined.
Results
The physician panel reached consensus on 219 (91.3%) of 
240 admissions. The panel identified 105 stroke admis-
sions,  93  of  which  had  been  identified  by  the  registry 
teams  (sensitivity  =  88.6%).  The  panel  identified  114 
nonstroke  admissions,  all  of  which  had  been  identified 
as nonstrokes by the registry teams (specificity = 100%). 
The positive and negative predictive value of the registry 
teams’ designation was 100% and 90.5%, respectively. The 
registry teams’ assessment of stroke subtype agreed with 
that of the panel in 78.5% of cases. Most discrepancies 
were related to the distinction between ischemic stroke 
and transient ischemic attack.
Conclusions
The accuracy of hospitals participating in a hospital-based 
stroke  registry  to  identify  acute  stroke  admissions  was 
very  good;  hospitals  tended  to  underreport  rather  than 
to overreport stroke admissions. Stroke registries should 
periodically conduct studies to ensure that the accuracy of 
case ascertainment is maintained.
Introduction
The accurate identification of acute stroke admissions is 
an  essential  requirement  for  hospital-based  stroke  reg-
istries; however, the process of accurately distinguishing 
acute stroke admissions from conditions that mimic stroke 
requires substantial clinical experience and knowledge (1). 
Similarly, the accurate identification of stroke subtypes 
is  important  for  quality  improvement–based  registries 
where  compliance  with  performance  measures  is  deter-
mined within specific subtypes.
A  handful  of  studies  have  assessed  the  reliability  or 
interobserver agreement of the clinical diagnosis of stroke 
and transient ischemic attack (TIA) (2-5) or have reported 
on the reliability of clinical stroke classification systems 
(5-7).  However,  few  reports  have  assessed  the  accuracy 
of clinical stroke diagnosis (8,9), and these studies were 
conducted  in  the  context  of  assessing  the  accuracy  of   
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physicians to identify stroke at the first point of medical 
contact. We could find no studies that have evaluated the 
accuracy  of  stroke  diagnoses  in  the  context  of  hospital-
based  registries  or  databanks.  We  therefore  conducted 
a  study  to  determine  the  ability  of  Michigan  hospital 
registry  teams  participating  in  a  prototype  of  the  Paul 
Coverdell National Acute Stroke Registry to prospectively 
identify acute stroke cases from among all possible stroke 
admissions.  Our objectives  were  to  determine  the  accu-
racy in Michigan hospitals of acute stroke admissions and 
specific stroke subtypes identified in a statewide stroke 
registry.
Methods
Registry design
The Michigan Acute Stroke Care Overview and Treatment 
Surveillance System (MASCOTS) was a statewide, hospi-
tal-based, acute stroke registry that was a prototype for 
the Paul Coverdell National Acute Stroke Registry (10,11). 
Details of the design of the MASCOTS registry have been 
published previously (12,13). Briefly, MASCOTS used a 
modified  stratified  sampling  regime  as  part  of  a single-
stage cluster design to obtain a sample of 16 Michigan 
hospitals. In the initial pilot phase of the project, 8 large 
academic-affiliated  hospitals  from  4  urban  communities 
participating  in  a  community-based  stroke  project  were 
selected. Another 8 hospitals were then randomly selected 
from the remaining 114 acute care hospitals according to 
size (12,13). The MASCOTS registry collected data during   
May through November 2002.
Hospital training, case ascertainment, and stroke subtype 
designation
All hospital personnel hired for the project attended a 
group training session before the start of data collection 
and had access to ongoing training and technical sup-
port throughout the data collection period (13). At each 
hospital, registry teams were defined as consisting of at 
least 1 nurse, who was either experienced in acute stroke 
care or was a member of the quality improvement staff, 
and a physician with interest in stroke who was trained 
in either neurology or emergency medicine. The stroke 
physician served as the project’s physician champion (ie, 
the physician who provided central leadership, consulta-
tion, and authority for the project within the hospital). 
Financial support was provided to each hospital so that 
the lead registry nurse could work on the project between 
a quarter to half-time, depending on the size of the stroke 
case load.
Hospital personnel were instructed to identify all acute 
stroke admissions during May through November 2002 by 
using prospective case ascertainment methods, defined as 
the active, systematic, and regular screening of all poten-
tial admissions that does not rely on the use of discharge 
diagnosis codes (14). Each registry team was instructed 
to regard all consecutive hospital admissions of patients 
aged 18 or older who had a chief complaint or clinical signs 
and symptoms consistent with acute stroke as suspected 
stroke cases and to record them in a MASCOTS logbook. 
The registry teams identified suspect acute stroke admis-
sions by using “hot pursuit” case ascertainment methods 
(14), which involved the active and regular review of all 
data  sources  that  identify  potential  admissions.  These 
include  the  admission  logs  from  the  emergency  depart-
ment (ED), intensive care unit (ICU), and hospital wards, 
and neurology consultation logs.
Within 72 hours after the hospital admission, the registry 
team was instructed to make a judgment about whether a 
particular suspect stroke case was either a probable acute 
stroke (defined as a ≥90% probability), not an acute stroke 
(defined as a <5% probability), or a possible acute stroke 
(defined as ≥5% to <90% probability). Probable and pos-
sible acute stroke cases were then assigned a MASCOTS 
Study Identification (ID) number on the log book. Cases 
were included in the final registry if they met 1 of the 
Coverdell acute stroke subtype case definitions adapted 
from previous work (15): ischemic stroke (IS), intracerebral 
hemorrhage (ICH), subarachnoid hemorrhage (SAH), TIA,   
ischemic stroke of uncertain duration (ISUD), and stroke 
of uncertain type (11). The final case status was deter-
mined by the registry team once the completed medical 
record became available after the patient was discharged. 
This  determination  was  made  on  the  basis  of  detailed 
review of the Coverdell case definitions (Appendix) and 
relied heavily on the results of all brain imaging studies 
and physician and nurse notes.
Independent hospital audit
As part of the registry’s quality assurance efforts (16), a 
research  nurse  (S.W.)  experienced  in  acute  stroke  con-
ducted  an  independent  audit  at  each  registry  hospital. 
The audits were conducted between 6 and 12 weeks after 
the  start  of  data  collection  and  hospitals  received  only   VOLUME 8: NO. 3
MAY 2011
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2 days’ notice of their audit date. Choosing a random start-
ing point in the MASCOTS logbook, the nurse selected 8 
sequential  admissions  that  had  been  designated  by  the 
registry team as probable or possible acute stroke cases, 
and 8 sequential admissions that had been identified as 
nonstroke cases. Each of the 16 admissions was assigned 
a unique audit ID number and underwent a full abstrac-
tion of the medical chart. The audit nurse had access to 
the same chart information as the registry team. Clinical 
information  relevant  to  the  diagnostic  process  (ie,  chief 
complaint, past medical history, ED presentation, imaging 
results, laboratory and diagnostic test results, consulta-
tion  summaries,  treatments,  hospital  course,  and  dis-
charge disposition) were recorded on a separate diagnostic 
abstraction form. Because 1 of the original 16 hospitals 
closed shortly after the start of registry enrollment, there 
were a total of 240 (ie, 16 × 15) completed audit cases. 
The original sample size of 256 (16 × 16) audit cases was 
designed  to  generate  overall  sensitivity  and  specificity 
estimates that were accurate within ±7% (17).
Review panel and Delphi process
In 2003 an independent panel of 4 physician coinvestiga-
tors (3 neurologists and 1 emergency medicine specialist) 
was  assembled  to  classify  each  admission  as  either  an 
acute stroke, nonstroke, or unclassifiable (if stroke status 
could not be determined). If a case was determined to be 
an acute stroke admission, panel members then assigned 
a Coverdell subtype definition by using the case definition 
criteria (Appendix). A Delphi process was used to facilitate 
consensus among panel members. The Delphi technique is 
a structured communication technique used to determine 
the extent of agreement and to reach consensus among 
experts (18). Each panel member received a copy of the 
240 diagnostic abstraction forms, which were blinded as 
to the registry team’s final designation of stroke or non-
stroke. For round 1, panel members recorded their find-
ings  on  an  electronic  spreadsheet  that  was  returned  to 
the main study office. Discrepancies in the assignment of 
acute stroke status and stroke subtype were then identi-
fied in an electronic report that documented the nature 
of the discrepancy and listed the anonymous answers of 
the 4 reviewers. This electronic report was then shared 
among the panel members who were then asked to either 
modify their classification or justify why it should remain 
the same. Two additional adjudication rounds were under-
taken to refine the designation of stroke versus nonstroke 
and the subtype designation, before holding a final face-
to-face meeting. The ultimate aim of this process was to   
maximize the proportion of cases for which there was com-
plete agreement among the 4 panel members. When the 
panel could not reach consensus on a case, the case was 
placed in the unclassifiable group.
Using the panel’s final determination as the gold stan-
dard, the accuracy of the registry teams’ final stroke des-
ignation was estimated by calculating the sensitivity (ie, 
the proportion of acute stroke admissions designated by 
the panel that were identified by the registry teams) and 
specificity (ie, the proportion of nonstroke admissions des-
ignated by the panel that were identified by the registry 
teams). Positive and negative predictive values of the reg-
istry teams’ designations were also calculated. Confidence 
intervals  (CIs)  were  calculated  by  using  Confidence 
Interval  Analysis  software  version  2.0.2  (University  of 
Southampton, Southampton, United Kingdom).
For cases in which the physician panel and hospital regis-
try teams agreed that the case represented an acute stroke 
admission, we assessed the agreement in Coverdell stroke 
subtypes between the panel and registry teams. Because 
of the small sample size for some of the subtypes, we were 
only able to assess the accuracy of the registry teams to 
identify IS. We used the panel’s designation of IS as the 
gold standard to calculate sensitivity (ie, the proportion of 
IS admissions designated by the panel that were identified 
by the registry teams) and specificity (ie, the proportion 
of non-IS admissions designated by the panel that were 
identified by the registry teams).
Results
Of  the  original  120  probable  or  possible  stroke  admis-
sions sampled, 96 (80%) were determined by the registry 
teams to have met the case definition for an acute stroke 
admission and were given a final Coverdell stroke subtype 
diagnosis.  The  24  cases  not  given  a  subtype  diagnosis 
by  the  registry  teams  were  considered  to  be  nonstroke 
admissions and were added to the original 120 nonstroke   
admissions,  making  a  total  of  144.  Of  the  240  cases 
reviewed by the physician panel, consensus on whether 
the  case  represented  an  acute  stroke  admission  was 
reached on 219 (91.3%). Of these, 105 were determined 
to be acute stroke admissions, and 114 nonstroke admis-
sions. The accuracy of hospital registry teams to identify 
acute stroke admissions was similar to that of the physi-
cian panel (Table 1). The overall sensitivity and specificity 
of the registry teams to identify acute stroke admissions VOLUME 8: NO. 3
MAY 2011
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was very high (88.6% and 100%, respectively) (Table 1). 
Similarly, the positive and negative predictive values of 
the  registry  teams’  determinations  were  also  very  high 
(100% and 90.5%, respectively).
The sensitivity of the hospital registry teams to identify 
acute stroke admissions was not 100% because of 12 cases 
that  were  determined  by  the  panel  to  be  acute  stroke 
admissions but were designated as nonstroke admissions 
by the registry teams. Six of these cases had originally 
been given a MASCOTS ID number in the logbook (ie, 
were  designated  a  probable  or  possible  acute  stroke). 
However,  this  status  was  changed  to  nonstroke  by  the 
registry team after final review although the clinical pre-
sentation and imaging results of all 6 cases appeared to 
be consistent with acute stroke. The other 6 cases were 
never given a MASCOTS ID number by the registry team; 
3 cases had no clinical symptoms or clinical symptoms that 
were resolving, 4 had negative imaging findings, and 2 did 
not have a neurology consult.
The calculations of sensitivity, specificity, and predictive 
values  did  not  include  data  on  the  21  cases  for  which 
the panel could not reach consensus (ie, were designated 
unclassifiable).  Three  of  these  cases  were  classified  as 
stroke cases by the hospitals, and 18 as nonstroke cases 
(note that the option to use the unclassifiable designation 
was not available to the registry teams). After detailed 
review of these cases, we found that 6 cases had equivo-
cal or resolving clinical symptoms, 19 had initial imaging 
findings that were negative for an acute or subacute stroke 
lesion, and only 6 had a definitive determination of stroke 
or TIA recorded in the chart based on a neurology consult. 
In 9 cases the original hospital designation of stroke was 
changed to nonstroke after the patient was discharged.
The physician panel and registry teams generally agreed 
on  the  Coverdell  stroke  subtype  diagnosis  (Table  2). 
Agreement on subtype was examined only among the 93 
cases for which both the panel and the hospitals agreed 
were  acute  stroke  admissions.  The  overall  agreement 
across all stroke subtypes was 78.5% (ie, 73 of 93). Of the 
67 cases designated as IS by the panel, the registry teams 
identified 55, resulting in a sensitivity of 82% (95% CI, 
71%-89%).  The  most  common  cause  of  discrepancies  in 
the identification of IS was the difficulty in distinguishing 
IS from TIA; 10 of the 12 false-negative IS designations 
were labeled as TIA cases by the registry teams, whereas 
5 of the 7 false-positive IS designations were labeled as 
TIA by the panel. Of the 26 cases designated as non-IS by 
the panel, the teams correctly identified 18, resulting in a 
specificity for the designation of non-IS of 69% (95% CI, 
50%-84%).
The prevalence of other subtypes was too low to calculate 
individual sensitivity and specificity estimates. However, 
overall, the registry teams agreed with the panel’s deter-
mination in 8 of 9 of the ICH cases, 4 of 6 of the SAH cases, 
3 of 8 of the TIA cases, and 3 of 3 of the ISUD cases.
Discussion
This study found that registry teams participating in a 
statewide hospital-based acute stroke registry were able 
to accurately identify suspect stroke admissions, success-
fully determine those that represented acute stroke cases, 
and assign an appropriate stroke subtype. We found that 
hospital  registry  teams  had  a  tendency  to  underreport 
rather than overreport acute stroke admissions. With the 
exception of 3 cases that the panel could not agree on, we 
found  no  evidence  of  false-positive  designations  by  the 
hospitals.  All  acute  stroke  admissions  identified  by  the 
registry teams were confirmed by the independent panel 
(specificity 100%, positive predictive value 100%). The ten-
dency of hospitals to underreport acute stroke admissions 
was reflected in the 12 false-negative cases, which resulted 
in a sensitivity of 88.6% (negative predictive value, 90.5%). 
For the 6 cases in which the original stroke designation 
was retracted by the hospitals after final review, we found 
that the clinical presentation and imaging results were all 
consistent with acute stroke. Thus, the change in designa-
tion to nonstroke after discharge appears to represent an 
error by the registry teams. The initial presentation and 
work-up of 4 of the other 6 false-negative cases was at 
least equivocal for an acute stroke admission, which helps 
explain  why  the  registry  teams  determined  them  to  be 
nonstroke admissions.
The lack of comparable studies precludes any meaningful 
comparison between the findings of this study (in terms 
of sensitivity and specificity) and other research.  Because 
this study assessed the final stroke designation after the 
subject had been discharged from the hospital, its results 
are not directly comparable to those of the few studies that 
have evaluated the accuracy of the initial stroke diagnoses 
obtained at the bedside or by emergency physicians (5-7). 
Although  our  data  on  the  accuracy  of  Coverdell  stroke   
subtype  diagnoses  were  limited  by  the  small  numbers 
of non-IS subtypes, our study was still able to illustrate VOLUME 8: NO. 3
MAY 2011
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the widely recognized problem of distinguishing between 
IS and TIA (19,20). There were 13 cases designated as 
TIA by the registry teams and 8 cases designated as TIA 
by the panel, yet in only 3 cases did the registry teams 
and panel agree. The clinical distinction between the 2 
subtypes required the documentation of the duration of 
symptoms (ie, <24 vs >24 hours), information that was 
frequently lacking in the medical chart. It should be noted 
that a new definition of TIA has been proposed (20), which 
relies  on  identifying  the  absence  of  acute  infarction  on 
brain imaging rather than on an arbitrary time period. 
However,  whether  this  new  definition  will  lead  to  an 
improvement in the ability to distinguish between TIA and 
IS is unknown.
The  Delphi  approach  provided  an  efficient  mechanism 
that enabled the expert panel to reach consensus on most 
of the cases they evaluated. We found good reasons why 
the panel was not able to reach consensus on the status of 
21 subjects. Although most cases had a combination of his-
tory and clinical findings that was consistent with an acute 
stroke onset, more than 90% had brain imaging findings 
that were negative for an acute stroke process. Whereas 5 
cases had a definitive stroke diagnosis after neurology con-
sultation (1 IS, 1 TIA, 1 hemorrhagic stroke, and 2 cases of 
TIA or IS), the panel thought that the evidence presented 
was not definitive for any of these cases.
One strength of this study is that it tested the accuracy of 
acute stroke case identification in a stroke registry that 
had a range of representative hospitals selected by using 
valid sampling methods (21). The selected hospitals had a 
range of capabilities and experiences with respect to acute 
stroke care — varying from large academic medical cen-
ters with extensive preexisting stroke capabilities to small 
rural hospitals with no experience in identifying and track-
ing acute stroke admissions. Our data show that training 
a diverse group of hospitals and staff to accurately identify 
acute stroke admissions is possible. Although the study 
was  not  designed  to  evaluate  the  performance  of  indi-
vidual hospitals, an evaluation of the 16 case abstractions 
from each hospital did not reveal any outliers in terms of 
a higher-than-expected error rate at a particular institu-
tion. To examine the effect of hospital size and capacity 
on our findings, we stratified the data into 2 groups of 
hospitals — the 8 large academic-affiliated hospitals that 
were involved in the pilot phase of the registry and the 
remaining 8 hospitals that were selected by stratified sam-
pling methods (this group included medium and smaller   
hospitals). We found that the sensitivity of stroke designa-
tions were the same (ie, 87% in the pilot phase hospitals 
and 90% in the second randomly selected group). Although 
the methods used to evaluate the accuracy of this registry 
are  generalizable  to  other  registries  and  hospitals,  our 
specific findings may not be. As suggested in the context 
of quality assurance for both epidemiologic studies (4) and 
disease registries (22), it is prudent to undertake periodic 
assessments of diagnostic accuracy to confirm that diag-
nostic biases or misapplication of case definition criteria 
have not occurred.
Our study also has limitations. First, the audit was con-
ducted during the early phase of the registry (between 6 
and 12 weeks of the start) so that any problems with case 
ascertainment or assignment of acute stroke case defini-
tions could be detected and corrected. Thus, the findings 
may not be representative of the long-term accuracy of 
the registry. The accuracy of the registry teams to identify 
acute stroke admissions and assign stroke subtypes may 
have changed as more experience was gained during the 
data collection period. Second, the small number of sub-
jects examined at each hospital precluded the presentation 
of hospital-specific findings. Similarly, the small number 
of non-IS subtypes prevented us from calculating sensitiv-
ity and specificity estimates for these subtypes. Finally, 
the only information available to the panel was the diag-
nostic abstraction form prepared by the research nurse. 
This information in turn was limited by the quality of the 
documentation in the medical chart. The panel’s determi-
nations may have been different if they had had full access 
to all of the original information, including imaging stud-
ies. However, such an approach was not feasible within 
the constraints of the study.
Our results illustrate that, with training, a diverse group 
of hospitals can accurately identify acute stroke admissions 
by  using  prospective  case  ascertainment  methods.  The 
assessment  of  a  registry’s  accuracy  and  completeness  is 
an essential step and should be undertaken soon after the 
start of a registry and periodically thereafter to ensure that 
accurate case ascertainment and case definition are main-
tained (22,23). We believe this process to be in the context of 
quality improvement registries, where the potential for bias 
in the selection of cases into the registry (whether occurring 
insidiously or otherwise) remains a possibility (24).VOLUME 8: NO. 3
MAY 2011
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Tables
Table 1. Overall Accuracy of Hospital Registry Teams to Identify Acute Stroke Admissions Relative to That of an Independent 
Physician Panel (N = 240)a
Registry Teams Classification
Independent Physician Panel Classification
Stroke Nonstroke Unclassifiable Total
N = 105 N = 114 N = 21 N = 240
Stroke 93 0 3 96
Nonstroke 12 114 18 144
 
Abbreviation: CI, confidence interval. 
a The independent physician panel was considered the gold standard. 
Sensitivity = 93/10 = 88.6% (9% CI, 81.1%-93.3%). 
Specificity = 114/114 = 100% (9% CI, 96.%-100%). 
Positive predictive value = 93/93 = 100% (9% CI, 96.0%-100%). 
Negative predictive value = 114/126 = 90.% (9% CI, 84.1%-94.%).
Table 2. Agreement of Coverdell Stroke Subtype Diagnosis Between the Independent Physician Panel and Hospital Registry Teams 
Among Confirmed Acute Stroke Admissions (N = 93) 
Registry Teams Classification
Independent Physician Panel Classification
IS 
(N = 67)
ICH 
(N = 9)
SAH 
(N = 6)
TIA 
(N = 8)
ISUD 
(N = 3)
IS (N = 62)  — 2  —
ICH (N = 9) 1 8 — — —
SAH (N = ) — 1 4 — —
TIA (N = 13) 10 — — 3 —
ISUD (N = 4) 1 — — — 3
 
Abbreviations: IS, ischemic stroke; ICH, intracerebral hemorrhage; SAH, subarachnoid hemorrhage; TIA, transient ischemic attack; ISUD, ischemic stroke of 
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Ischemic stroke (IS): A rapid onset of focal neurologic deficit with signs or 
symptoms persisting longer than 24 hours and not attributable to another 
disease process. Patients who, more than 24 hours after the onset of stroke, 
have only persistent sensory symptoms with minimal sensory signs or mild 
impairment of dexterity with normal muscle strength are included. Initial 
computerized axial tomography/magnetic resonance imaging (CT/MRI) may 
show evidence of acute IS or no evidence of stroke. When CT/MRI shows 
an area consistent with intracerebral hemorrhage, this may be seen only in 
cases with a hemorrhagic transformation of a cerebral infarct.
Intracerebral hemorrhage (ICH): Nontraumatic abrupt onset of severe 
headache, altered level of consciousness and/or focal neurologic deficit that 
is associated with a focal collection of blood within the brain parenchyma 
on CT or at autopsy and is not due to trauma or hemorrhagic conversion of 
a cerebral infarction. Cases of intraventricular hemorrhage without ICH or 
subarachnoid hemorrhage will be classified as ICH unless angiogram dem-
onstrates an aneurysm.
Subarachnoid hemorrhage (SAH): Nontraumatic abrupt onset of severe 
headache or altered level of consciousness that is associated with blood in 
the subarachnoid space on CT or at autopsy, or a clinical history and exami-
nation consistent with SAH (sudden onset of severe headache or altered 
level of consciousness) with xanthochromia and many red blood cells in the 
cerebrospinal fluid. Cases that have both ICH and SAH are classified as SAH 
if an aneurysmal source of bleeding is documented or if the study investiga-
tor suspects a subarachnoid origin of the bleeding. Cases are classified as 
ICH if a parenchymal source of bleeding seems most likely.
Transient ischemic attack (TIA): Patients with acute neurologic signs and 
symptoms that last less than 24 hours. Patients with transient symptoms 
that are associated with an appropriate lesion on CT/ MRI will be included 
as a TIA but not as a case of cerebral infarction. Exclude patient if symptoms 
no longer exist at presentation to the emergency department.
Ischemic stroke of uncertain duration (ISUD): Rapid onset of a major focal 
neurologic deficit that is consistent with cerebral infarction but the duration 
of which symptoms could not be confirmed as lasting longer than 24 hours. 
This category is therefore used when there is insufficient information to dis-
tinguish among IS and TIA.
Stroke of uncertain type: Rapid onset of a major focal neurologic deficit that 
persists more than 24 hours or is fatal and cannot be attributed to another 
cause. This category is used when radiographic or pathologic information is 
insufficient to distinguish among cerebral infarction, ICH, and SAH.
Appendix. Coverdell Acute Stroke Subtype Case Definitions